T(2) mapping of the meniscus is a biomarker for early osteoarthritis

半月板的T2映射是早期骨关节炎的生物标志物

阅读:1

Abstract

PURPOSE: To evaluate in vivo T(2) mapping as quantitative, imaging-based biomarker for meniscal degeneration in humans, by studying the correlation between T(2) relaxation time and degree of histological degeneration as reference standard. METHODS: In this prospective validation study, 13 menisci from seven patients with radiographic knee osteoarthritis (median age 67 years, three males) were included. Menisci were obtained during total knee replacement surgery. All patients underwent pre-operative magnetic resonance imaging using a 3-T MR scanner which included a T(2) mapping pulse sequence with multiple echoes. Histological analysis of the collected menisci was performed using the Pauli score, involving surface integrity, cellularity, matrix organization, and staining intensity. Mean T(2) relaxation times were calculated in meniscal regions of interest corresponding with the areas scored histologically, using a multi-slice multi-echo postprocessing algorithm. Correlation between T(2) mapping and histology was assessed using a generalized least squares model fit by maximum likelihood. RESULTS: The mean T(2) relaxation time was 22.4 ± 2.7 ms (range 18.5-27). The median histological score was 10, IQR 7-11 (range 4-13). A strong correlation between T(2) relaxation time and histological score was found (r(s) = 0.84, CI 95% 0.64-0.93). CONCLUSION: In vivo T(2) mapping of the human meniscus correlates strongly with histological degeneration, suggesting that T(2) mapping enables the detection and quantification of early compositional changes of the meniscus in knee OA. KEY POINTS: • Prospective histology-based study showed that in vivo T (2) mapping of the human meniscus correlates strongly with histological degeneration. • Meniscal T (2) mapping allows detection and quantifying of compositional changes, without need for contrast or special MRI hardware. • Meniscal T (2) mapping provides a biomarker for early OA, potentially allowing early treatment strategies and prevention of OA progression.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。